TCL-6 Inhibitors
TCL-6 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the TCL-6 gene and its associated protein products. TCL-6, or T-cell leukemia/lymphoma 6, is a gene located within a highly conserved region of the human genome, often associated with a cluster of genes involved in cell cycle regulation and apoptosis. Although the exact function of the TCL-6 protein remains not fully understood, it is believed to play a role in regulating cell proliferation and possibly apoptosis, particularly in T-cells and other immune-related cells. By inhibiting TCL-6, these compounds are able to interfere with the cellular processes controlled by this gene, which may include the regulation of signaling pathways related to cell growth and death.
Research into TCL-6 inhibitors is important for understanding the gene's role in cellular regulation and how it interacts with other genes within its cluster. By using these inhibitors, scientists can explore the downstream effects of disrupted TCL-6 activity on cellular growth, differentiation, and programmed cell death. Additionally, TCL-6 inhibition offers insight into the broader regulatory networks that govern immune cell function and their responses to external stimuli. These inhibitors help elucidate the molecular mechanisms by which TCL-6 might influence cell cycle checkpoints, apoptosis, and immune system regulation. Through the use of TCL-6 inhibitors, researchers can gain a deeper understanding of the protein's function and its potential role in maintaining cellular balance and homeostasis, shedding light on the complexity of gene regulation in immune and non-immune cells alike.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Tyrosine kinase inhibitor that can influence multiple hematopoietic signaling pathways, potentially affecting TCL-6 activities indirectly. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Targets multiple tyrosine kinases. Given the broad role of tyrosine kinases in hematopoiesis, it can indirectly modulate TCL-6's function. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
Targets the JAK/STAT pathway, a crucial signaling pathway in hematopoietic cells, and can have downstream effects on TCL-6 function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that affects various cellular processes in hematopoietic cells, potentially influencing TCL-6's role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that impacts the MAPK pathway, a crucial signaling cascade in hematopoietic cells that can have downstream effects on TCL-6. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a central regulator of cell growth and proliferation in hematopoietic cells. This inhibition can indirectly modulate TCL-6 function. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Bruton's tyrosine kinase (BTK) inhibitor that affects B-cell receptor signaling. It can have downstream effects on TCL-6 in hematopoietic cells. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that affects multiple hematopoietic cell signaling pathways, potentially impacting TCL-6 functions indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
P38 MAPK inhibitor that affects hematopoietic cell signaling and might indirectly influence TCL-6 function. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor. By affecting DNA methylation patterns in hematopoietic cells, it can potentially modulate TCL-6's function. | ||||||